US Broker Ratings

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amid a 64.85% Return on Equity

DaVita Inc. (DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is making waves with its impressive return on equity (ROE) of 64.85%. This..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Genetic Medicine Leader with 13.63% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the biotechnology sector, making significant strides in the genetic medicine landscape. With a market cap of $8.06 billion, this Pittsburgh-based..

Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its innovative therapies targeting ophthalmic conditions. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth with a 7.05% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to make strides in the competitive landscape of oncology treatment. With a focus on developing and commercializing novel..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity

TransMedics Group, Inc. (Nasdaq: TMDX) is rapidly gaining attention in the healthcare sector, specifically in the medical devices industry. The company is revolutionizing organ transplant therapy with its innovative Organ..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a Potential 12.9% Upside Amid Mixed Analyst Ratings

Oscar Health, Inc. (OSCR), a healthcare technology company headquartered in New York, is garnering attention from investors due to its innovative approach to healthcare plans and its intriguing potential for..

BeOne Medicines Ltd. (ONC) Stock Analysis: 29.95% Potential Upside in Oncology Innovation

BeOne Medicines Ltd. (ONC), a Swiss-based biotech powerhouse, is capturing investors’ attention with its robust oncology-focused pipeline and impressive revenue growth. With a market capitalization of $35.08 billion, this healthcare..

Alkermes plc (ALKS) Stock Analysis: Exploring a 45% Potential Upside in Biopharma

Alkermes plc (NASDAQ: ALKS) stands as a notable player in the biopharmaceutical sector, focusing on addressing unmet medical needs across a spectrum of therapeutic areas. Based in Dublin, Ireland, the..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 11.20% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with a notable 11.20% potential upside, as indicated by its average target price of $46.07. As a key player..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Understanding the 25.56% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies aimed at treating rare diseases. With a market capitalization of..

Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing for animals. With a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Research Sector with 10.48% Upside Potential

For investors keen on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) offers a unique blend of opportunities within the diagnostics and research industry. With a market capitalization..

Axsome Therapeutics (AXSM): Analyst Consensus Highlights 35% Potential Upside for This Biotech Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a New York-based biopharmaceutical company, continues to capture investor attention with its focus on developing therapies for central nervous system (CNS) disorders. With a market..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Impressive Growth Potential Amidst Innovative Biotechnology Advances

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its robust pipeline of clinical-stage biopharmaceuticals. Headquartered in London, United Kingdom,..

TG Therapeutics, Inc. (TGTX) Growth Potential: Navigating a 47.65% Upside in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is making waves with its promising pipeline and substantial market potential. With a market capitalization of $4.78 billion,..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 1.87% Upside with Robust Revenue Growth

Bausch + Lomb Corporation (NYSE: BLCO), a prominent name in the healthcare sector, is making waves in the medical instruments and supplies industry. With its Canadian roots and a market..

Option Care Health, Inc. (OPCH) Investor Outlook: Capitalizing on a 23.51% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector with a focus on medical care facilities, stands out as a formidable player in the home and alternate..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Pivotal Moment with a 0.28 Forward P/E

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, is a name that resonates with both generic and specialty drug manufacturing. Based in India, this pharmaceutical giant..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 178.79% Potential Upside in Rare Disease Therapeutics

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is gaining attention in the biotechnology sector, with a market capitalization of $2.1 billion and a promising focus on rare disease therapeutics. Headquartered in Redwood..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 10.66% Upside Awaits Investors

Investors searching for a promising opportunity in the healthcare sector might find GE HealthCare Technologies Inc. (GEHC) to be a compelling option. With a market capitalization of $38.41 billion, GEHC..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds